MediWound (MDWD) Cash & Equivalents (2016 - 2025)

MediWound has reported Cash & Equivalents over the past 10 years, most recently at $4.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $4.8 million for Q4 2025, down 47.58% from a year ago — trailing twelve months through Dec 2025 was $4.8 million (down 47.58% YoY), and the annual figure for FY2025 was $4.8 million, down 47.58%.
  • Cash & Equivalents for Q4 2025 was $4.8 million at MediWound, down from $9.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for MDWD hit a ceiling of $33.9 million in Q4 2022 and a floor of $4.8 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $11.0 million (2021), compared with a mean of $14.2 million.
  • Biggest five-year swings in Cash & Equivalents: soared 206.85% in 2022 and later crashed 64.99% in 2023.
  • MediWound's Cash & Equivalents stood at $11.0 million in 2021, then soared by 206.85% to $33.9 million in 2022, then crashed by 64.99% to $11.9 million in 2023, then decreased by 22.85% to $9.2 million in 2024, then plummeted by 47.58% to $4.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $4.8 million (Q4 2025), $9.2 million (Q4 2024), and $11.9 million (Q4 2023) per Business Quant data.